4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-22-011715
Options or other derivatives
- Chief Operating Officer acquired 180,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sloan Leslie · Chief Operating Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-17 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +180,000 | 180,000 | D |
Loading xslF345X03/doc4.xml…